SCHEMBL8545552

SCHEMBL8545552

CC(C)Oc1c(Br)cc(Br)cc1C(=O)Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.47
LMNA P02545 2/20 0.41
ALOX12 P18054 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
AKR1C4 P17516 1/20 0.37
AKR1C3 P42330 1/20 0.37
AKR1C2 P52895 1/20 0.37
AKR1C1 Q04828 1/20 0.37
HTT P42858 2/20 0.34
ALDH1A1 P00352 2/20 0.34
THRB P10828 3/20 0.34
THRA P10827 2/20 0.34
MAOB P27338 2/20 0.34
MAOA P21397 1/20 0.34
POLB P06746 2/20 0.34
AR P10275 1/20 0.33
MEN1 O00255 1/20 0.33
EGFR P00533 1/20 0.33
ERBB2 P04626 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8541393 0.85 HSD17B10 (0.67) HSD17B10LMNAALOX12NPSR1AKR1C4
SCHEMBL765589 0.78 ALOX12 (0.47) HSD17B10LMNAALOX12NPSR1HTT
SCHEMBL31606917 0.73 AR (0.47) HSD17B10LMNAALOX12NPSR1HTT
SCHEMBL7682107 0.70 AKR1C3 (0.47) HSD17B10LMNAALOX12AKR1C4AKR1C3
SCHEMBL985501 0.69 FAAH (0.55) HSD17B10LMNAALOX12HTTALOX15
SCHEMBL4499977 0.69 ERN1 (0.49) HSD17B10LMNAALDH1A1MEN1CYP1A2
SCHEMBL29844644 0.69 HSD17B10 (0.46) HSD17B10ALDH1A1THRBTHRAPOLB
SCHEMBL11760933 0.69 AKR1C4 (0.67) HSD17B10LMNAAKR1C4AKR1C3AKR1C2
SCHEMBL28166753 0.69 AKR1C4 (0.45) HSD17B10LMNAAKR1C4AKR1C3AKR1C2
SCHEMBL1457729 0.68 TPMT (0.56) HSD17B10HTTALDH1A1THRBTHRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0654023-B1 5-(2-OXYPHENYL)-PYRROLE DERIVATIVES AS DOPAMINE D3 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1998-09-16 EP disclosed
US-5523299-A ADMINISTERING IN TREATMENT OF PSYCHOTIC DISORDERS SMITHKLINE BEECHAM PLC (GB) 1996-06-04 US disclosed
EP-0654023-A1 5-(2-OXYPHENYL)-PYRROLE DERIVATIVES AS DOPAMINE D3 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1995-05-24 EP disclosed
WO-1994003426-A1 5-(2-OXYPHENYL)-PYRROLE DERIVATIVES AS DOPAMINE D3 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1994-02-17 WO disclosed